Nisa Investment Advisors, LLC Novo Cure LTD Transaction History

Nisa Investment Advisors, LLC

  • $24.1 Billion
  • Q4 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 4,321 shares of NVCR stock, worth $113,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,321
Previous 2,746 57.36%
Holding current value
$113,080
Previous $42,000 204.76%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$14.54 - $33.41 $22,900 - $52,620
1,575 Added 57.36%
4,321 $128,000
Q3 2024

Oct 24, 2024
SELL
$15.61 - $23.34 $483 - $723
-31 Reduced 1.12%
2,746 $42,000
Q2 2024

Jul 19, 2024
BUY
$11.83 - $24.05 $32,851 - $66,786
2,777 New
2,777 $47,000
Q1 2023

May 02, 2023
BUY
$56.44 - $118.81 $221,131 - $465,497
3,918 Added 46.55%
12,334 $742,000
Q4 2022

Feb 02, 2023
SELL
$63.98 - $85.37 $68,074 - $90,833
-1,064 Reduced 11.22%
8,416 $617,000
Q3 2022

Nov 07, 2022
BUY
$67.99 - $89.57 $529,982 - $698,198
7,795 Added 462.61%
9,480 $718,000
Q2 2022

Aug 03, 2022
SELL
$56.6 - $89.9 $43,865 - $69,672
-775 Reduced 31.5%
1,685 $117,000
Q4 2021

Feb 03, 2022
SELL
$75.08 - $121.99 $94,450 - $153,463
-1,258 Reduced 33.84%
2,460 $169,000
Q3 2021

Oct 18, 2021
SELL
$116.17 - $194.55 $478,039 - $800,573
-4,115 Reduced 52.53%
3,718 $432,000
Q2 2021

Aug 06, 2021
BUY
$130.4 - $225.58 $61,809 - $106,924
474 Added 6.44%
7,833 $1.74 Million
Q1 2021

Apr 26, 2021
BUY
$124.11 - $190.17 $311,019 - $476,566
2,506 Added 51.64%
7,359 $973,000
Q4 2020

Jan 25, 2021
BUY
$112.16 - $174.14 $275,689 - $428,036
2,458 Added 102.63%
4,853 $840,000
Q2 2020

Jul 27, 2020
SELL
$57.2 - $74.41 $28,886 - $37,577
-505 Reduced 17.41%
2,395 $142,000
Q1 2020

Apr 17, 2020
BUY
$57.05 - $95.75 $32,518 - $54,577
570 Added 24.46%
2,900 $195,000
Q4 2019

Jan 17, 2020
BUY
$68.3 - $93.8 $9,562 - $13,132
140 Added 6.39%
2,330 $196,000
Q3 2019

Oct 17, 2019
BUY
$61.86 - $97.8 $5,567 - $8,802
90 Added 4.29%
2,190 $164,000
Q1 2019

Apr 17, 2019
SELL
$31.96 - $56.12 $3,196 - $5,612
-100 Reduced 4.55%
2,100 $101,000
Q4 2018

Jan 17, 2019
BUY
$28.72 - $52.63 $14,360 - $26,315
500 Added 29.41%
2,200 $74,000
Q2 2018

Jul 19, 2018
SELL
$19.85 - $32.0 $198,500 - $320,000
-10,000 Reduced 85.47%
1,700 $53,000
Q4 2017

Jan 12, 2018
SELL
$16.3 - $21.9 $4,890 - $6,570
-300 Reduced 2.5%
11,700 $236,000
Q3 2017

Oct 13, 2017
BUY
$18.05 - $21.75 $216,600 - $261,000
12,000
12,000 $238,000

Others Institutions Holding NVCR

# of Institutions
262
Shares Held
76.9M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.75B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email